Bayer Launches Medrad Mark 7 Arterion Angiography Injection System
June 22, 2012 — Bayer HealthCare’s Radiology and Interventional unit has launched the new Mark 7 Arterion Injection System, the latest in the Medrad Mark series of angiographic injectors.
The system is light and maneuverable with features that are meant to simplify the delivery of contrast media used in angiograms to determine the extent of arterial blockage.
The first Medrad Mark injector was introduced for use in angiograms more than 40 years ago. The Arterion injection system joins the company’s portfolio of interventional devices used to restore blood flow — providing physicians a complimentary line of products to diagnose and treat cardiovascular disease.
For more information: www.bayerhealthcare.com